期刊文献+

PTEN在喉癌中的表达及其与DNA含量的关系

The Relationship Between the Expression of PTEN and the DNA Content In Laryngeal Carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨喉癌中PTEN的表达及其与DNA含量的关系。方法:采用免疫组化S-P法和流式细胞术,检测PTEN基因蛋白在60例喉鳞状细胞癌、15例喉乳头状瘤及10例正常黏膜的表达及DNA含量。结果:①PTEN蛋白表达定位于细胞质,PTEN蛋白阴性占18.3%(11/60),表达减低者占30%(18/60),阳性表达者占51.7%(31/60),PTEN与组织分化程度、临床分期相关。②喉癌的DI值高于对照组(P<0.05)。PTEN阳性的喉癌细胞DNA含量明显低于阴性组(P<0.05)。结论:PTEN在喉癌的发生发展中起着重要的作用,它的检测对喉癌的判定、预后和进一步治疗提供有效的依据。 Objective:To investigate the relationship between the expression of PTEN and the DNA content in laryngeal carcinoma.Methods:Expression of PTEN protein was measured with immunohistochemistry method and the DNA quantitative was measured with flow cytometry in 60 cases of laryngeal squamous cell carcinoma,15 cases of larynx papilloma and 10 cases of normal laryngeal mucosa.Results:①PTEN,being show in the cytoplasm,was negative in 18.3 %,reduced in 30% and positive in 51.7%.PTEN expression level was correlated with differentiation degree and clinical stages.②The DNA index of laryngeal carcinoma group was higher than that of other groups(P〈0.05).The DNA index of laryngeal carcinoma whose expression of PTEN protein was positive was significantly lower than that of negative.Conclusion:This experiment suggests that PTEN may play certain roles in the oncogengsis and progression of laryngeal carcinoma.Detection of the gene prducts has positive offects on early diagnosis,malignancy determination prognosis and treatment of laryngeal carcinoma.
作者 赵辉 彭诗东
出处 《内蒙古医学杂志》 2009年第11期1298-1300,共3页 Inner Mongolia Medical Journal
关键词 喉鳞状细胞癌 PTEN CYCLIND1 免疫组化 流式细胞术 Laryngeal squamous carcinoma PTEN CYCLINDI Immunohistochemistry Flow cytometry
  • 相关文献

参考文献11

  • 1Steck PA, Pershouse MA, Jasser SA, et al. Indenfification of a candidate tumor suppressor gene, MMACL, at chromosome 10q 23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15( 5):356- 362.
  • 2Lee JO, Yang H, Georgescu MM, et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and me mbrane association [ J ]. Cell, 1999, 99(3) :323 - 334.
  • 3Mauro L, Sisci D. Alpha5 betal integrin interactions regulate breast cancer cell adhesion and molibillty [ J ]. Exp Cell Res, 1999, 252 (5) :439- 448.
  • 4Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression P27 and cyclin D1 expression, in primay epithelial ovarian carcinomas[J] .Am J Pathol, 2001, 158:2 097 - 2 106.
  • 5Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer[J]. Mod Pathol, 2001, 14:672- 676.
  • 6Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell - cycle regulators p27kip1 and cyclin E, anlone and incombination, correlate with survival in young breast cancer patients [ J ]. Nat Med, 1997, 3:222 - 225.
  • 7米登海,易继林,刘恩宇,李兴睿.血管内皮生长因子与抑癌基因PTEN在肝细胞癌组织中表达及临床意义[J].中华肿瘤防治杂志,2006,13(15):1158-1162. 被引量:16
  • 8刘恩宇,易继林,宋炜,周旭,李兴睿,陈晚平.肝细胞癌组织中抑癌基因PTEN与pAkt的表达及其相关性研究[J].中华肿瘤防治杂志,2006,13(1):51-54. 被引量:12
  • 9袁火忠,湛本珠,何春.乳腺癌组织中PTEN和p27^(kip1)蛋白的表达及其相互关系[J].中华肿瘤防治杂志,2006,13(3):190-192. 被引量:11
  • 10Kapueuoglu N , Aktepe F , Kaya H , et al. lmmunohis Ochecal expression of PTEN in normal, hyperplastic and malignant endometrium and its correlatoion with hormone receptors, bcl - 2, bax, and apoptotic index [ J ]. Pathol Res Pract, 2007, 203 (3) : 153 - 162.

二级参考文献33

  • 1Di-Cristofano A,Pandolfi P P.The multiple roles of PTEN in tumor suppression[J].Cell,2000,18,100(4):387-390.
  • 2Sarbassov D D,Guertin D A,Ali S M.Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J].Science,2005,307 (5712):1098-1101.
  • 3Wendel H G,De Stanchina E,Fridman J S,et al.Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy[J].Nature,2004,428 (6980):332-337.
  • 4Washington K.Mass of liver[A].Mills S E.Sternberg's diagno-stic surgical pathology[C].4th ed.Philadelphia:Lippincott Williams & Wilkins,2004:1757.
  • 5Anonymous.The Cancer of the Liver Italian Program (CLIP)Investigators.A new prognostic system for hepatocellular carcinoma:a retrospective study of 435 patients[J].Hepatology,1998,28(3):751-755.
  • 6Perren A,Weng L P,Boag A H,et al.Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomasofthebreast[J].AmJ Pathol,1999,155(4):1253-1260.
  • 7Ayala G,Thompson T,Yang G,et al.High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence[J].Clin Cancer Res,2004,10(19):6572-6578.
  • 8Kawamura N,Nagai H,Bando K,et al.PTEN/MMAC1 mutations in hepatocellular carcinomas:somatic inactivation of both alleles in tumors[J].Jpn J Cancer Res,1999,90(4):413-418.
  • 9Fujiwara Y,Hoon D S,Yamada T,et al.PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas[J].Jpn J Cancer Res,2000,91(3):287-292.
  • 10Rahman M A,Kyriazanos I D,Ono T,et al.Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients:possible relationship with Cox Ⅱ and inducible nitric oxide synthase[J].In J Cancer,2002,100(2):152-157.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部